UBS Group’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.51M | Sell |
5,006,284
-1,065,148
| -18% | -$1.36M | ﹤0.01% | 3766 |
|
|
2026
Q1 | $6.92M | Buy |
6,071,432
+718,648
| +13% | +$885K | ﹤0.01% | 3730 |
|
|
2025
Q4 | $6.74M | Buy |
5,352,784
+577,248
| +12% | +$803K | ﹤0.01% | 3718 |
|
|
2025
Q3 | $7.4M | Sell |
4,775,536
-944,096
| -17% | -$1.3M | ﹤0.01% | 3617 |
|
|
2025
Q2 | $7.55M | Buy |
5,719,632
+3,302,579
| +137% | +$4.51M | ﹤0.01% | 3414 |
|
|
2025
Q1 | $4.01M | Sell |
2,417,053
-2,405,794
| -50% | -$3.96M | ﹤0.01% | 4014 |
|
|
2024
Q4 | $7.09M | Buy |
4,822,847
+3,976,423
| +470% | +$6.08M | ﹤0.01% | 3445 |
|
|
2024
Q3 | $1.26M | Buy |
846,424
+180,308
| +27% | +$268K | ﹤0.01% | 4433 |
|
|
2024
Q2 | $833K | Sell |
666,116
-370,534
| -36% | -$480K | ﹤0.01% | 4579 |
|
|
2024
Q1 | $1.24M | Sell |
1,036,650
-376,650
| -27% | -$377K | ﹤0.01% | 4420 |
|
|
2023
Q4 | $2.13M | Buy |
1,413,300
+399,290
| +39% | +$577K | ﹤0.01% | 3753 |
|
|
2023
Q3 | $1.62M | Buy |
1,014,010
+563,546
| +125% | +$1.03M | ﹤0.01% | 3646 |
|
|
2023
Q2 | $978K | Buy |
450,464
+140,294
| +45% | +$219K | ﹤0.01% | 4273 |
|
|
2023
Q1 | $453K | Buy |
310,170
+86,000
| +38% | +$111K | ﹤0.01% | 4773 |
|
|
2022
Q4 | $280K | Buy |
224,170
+5,632
| +3% | +$8.88K | ﹤0.01% | 5185 |
|
|
2022
Q3 | $413K | Buy |
218,538
+47,049
| +27% | +$111K | ﹤0.01% | 4515 |
|
|
2022
Q2 | $434K | Sell |
171,489
-707,897
| -80% | -$2.06M | ﹤0.01% | 4363 |
|
|
2022
Q1 | $3.03M | Buy |
879,386
+157,935
| +22% | +$558K | ﹤0.01% | 3048 |
|
|
2021
Q4 | $3.47M | Sell |
721,451
-95,826
| -12% | -$388K | ﹤0.01% | 3226 |
|
|
2021
Q3 | $2.98M | Buy |
817,277
+30,948
| +4% | +$115K | ﹤0.01% | 3212 |
|
|
2021
Q2 | $3.18M | Sell |
786,329
-721,691
| -48% | -$2.83M | ﹤0.01% | 3130 |
|
|
2021
Q1 | $6.47M | Buy |
1,508,020
+793,262
| +111% | +$3.79M | ﹤0.01% | 2339 |
|
|
2020
Q4 | $2.82M | Sell |
714,758
-1,882,052
| -72% | -$7.86M | ﹤0.01% | 3045 |
|
|
2020
Q3 | $9.58M | Buy |
2,596,810
+2,180,531
| +524% | +$9.2M | ﹤0.01% | 1669 |
|
|
2020
Q2 | $1.42M | Sell |
416,279
-368,149
| -47% | -$825K | ﹤0.01% | 3197 |
|
|
2020
Q1 | $1.05M | Sell |
784,428
-706,860
| -47% | -$1.11M | ﹤0.01% | 3302 |
|
|
2019
Q4 | $2.19M | Buy |
1,491,288
+241,552
| +19% | +$404K | ﹤0.01% | 3461 |
|
|
2019
Q3 | $2.61M | Buy |
1,249,736
+511,041
| +69% | +$1.04M | ﹤0.01% | 3042 |
|
|
2019
Q2 | $1.8M | Sell |
738,695
-608,010
| -45% | -$1.33M | ﹤0.01% | 3241 |
|
|
2019
Q1 | $3.52M | Sell |
1,346,705
-3,420
| -0.3% | -$10.4K | ﹤0.01% | 2495 |
|
|
2018
Q4 | $4.06M | Buy |
1,350,125
+794,513
| +143% | +$2.69M | ﹤0.01% | 2344 |
|
|
2018
Q3 | $1.92M | Buy |
555,612
+49,673
| +10% | +$264K | ﹤0.01% | 3247 |
|
|
2018
Q2 | $2.38M | Sell |
505,939
-1,435,999
| -74% | -$5.45M | ﹤0.01% | 3010 |
|
|
2018
Q1 | $6.16M | Buy |
1,941,938
+224,392
| +13% | +$904K | ﹤0.01% | 2119 |
|
|
2017
Q4 | $8.42M | Sell |
1,717,546
-1,184,016
| -41% | -$6.87M | ﹤0.01% | 1875 |
|
|
2017
Q3 | $19.9M | Buy |
2,901,562
+1,672,275
| +136% | +$10.5M | 0.01% | 1103 |
|
|
2017
Q2 | $8.09M | Buy |
1,229,287
+451,063
| +58% | +$3.16M | ﹤0.01% | 1719 |
|
|
2017
Q1 | $6.23M | Buy |
778,224
+280,500
| +56% | +$2.36M | ﹤0.01% | 1900 |
|
|
2016
Q4 | $4.63M | Sell |
497,724
-484,632
| -49% | -$5.01M | ﹤0.01% | 2163 |
|
|
2016
Q3 | $10.4M | Sell |
982,356
-91,123
| -8% | -$907K | 0.01% | 1379 |
|
|
2016
Q2 | $10M | Buy |
1,073,479
+752,514
| +234% | +$7.64M | 0.01% | 1379 |
|
|
2016
Q1 | $3.33M | Sell |
320,965
-400,971
| -56% | -$3.66M | ﹤0.01% | 2226 |
|
|
2015
Q4 | $7.26M | Buy |
721,936
+286,787
| +66% | +$2.87M | ﹤0.01% | 1660 |
|
|
2015
Q3 | $3.66M | Buy |
435,149
+201,705
| +86% | +$2.67M | ﹤0.01% | 2197 |
|
|
2015
Q2 | $3.75M | Sell |
233,444
-56,470
| -19% | -$878K | ﹤0.01% | 2366 |
|
|
2015
Q1 | $4.11M | Sell |
289,914
-6,185
| -2% | -$80.5K | ﹤0.01% | 2238 |
|
|
2014
Q4 | $2.96M | Buy |
+296,099
| New | +$2.53M | ﹤0.01% | 2538 |
|
Other funds holding OPK
RCMNY
WCM
HCM
UBS Group's OPK Position: Q2 2026 in Review
UBS Group reduced its Opko Health (OPK) stake by 18% in Q2 2026, selling an estimated $1.36M and leaving 5,006,284 shares worth $7.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3766.
UBS Group first reported a position in OPK in Q4 2014 and has held it in 47 quarters since. The position peaked at $19.9M in Q3 2017. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- UBS Group held 5,006,284 shares of Opko Health worth $7.51M as of Q2 2026.
- UBS Group sold 1,065,148 Opko Health shares in Q2 2026, an estimated $1.36M.
- Opko Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3766 holding.
- UBS Group first reported a position in Opko Health in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Opko Health position peaked at $19.9M in Q3 2017.
- 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.